Intralipid: having leapt, should we now check the view?
Alfred
S P
SP
Royal Adelaide Hospital, Emergency Department, North Terrace, Adelaide 5000, Australia. sam.alfred@health.sa.gov.au
D000779:Anesthetics, Local / Q000009:adverse effects*; D000931:Antidotes / Q000627:therapeutic use*; D004655:Emulsions / Q000009:adverse effects / Q000627:therapeutic use; D004739:England; D005217:Fat Emulsions, Intravenous / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010743:Phospholipids / Q000009:adverse effects / Q000627:therapeutic use*; D013024:Soybean Oil / Q000009:adverse effects / Q000627:therapeutic use*; D014852:Wales
D000779:Anesthetics, Local; D000931:Antidotes; D004655:Emulsions; D005217:Fat Emulsions, Intravenous; D010743:Phospholipids; C545823:soybean oil, phospholipid emulsion; D013024:Soybean Oil